ADX10059 as a Monotherapy in Patients With Gastroesophageal Reflux (GERD)

PHASE2CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

October 31, 2009

Conditions

Gastroesophageal Reflux

Interventions

DRUG

ADX10059

oral administration

DRUG

ADX10059 Matching Placebo

oral administration

Trial Locations (11)

Wien, Vienna

Leuven, Leuven

Bordeaux, Bordeaux

Lyon, Lyon

Nantes, Nantes

Berlin, Berlin

Dresden, Dresden

Gorlitz, Görlitz

Leipzig, Leipzig

Madgeburg 12, Magdeburg

Magdeburg 13, Magdeburg